{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T23:50:00Z","timestamp":1785887400906,"version":"3.56.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["ZIA BC 011773"],"award-info":[{"award-number":["ZIA BC 011773"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.canlet.2026.218668","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T07:27:34Z","timestamp":1781076454000},"page":"218668","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The WYZ-1 mouse glioblastoma stem cell model: A novel preclinical tool for tumor and therapy studies"],"prefix":"10.1016","volume":"656","author":[{"given":"Qingfeng","family":"Xue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5232-0474","authenticated-orcid":false,"given":"Samik","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyu","family":"Sang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuran","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanrun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5295-5437","authenticated-orcid":false,"given":"Jeeva","family":"Munasinghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunzhang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2293-4819","authenticated-orcid":false,"given":"Herui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0009-7370","authenticated-orcid":false,"given":"Zhengping","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2026.218668_bib1","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1056\/NEJMra0708126","article-title":"Malignant gliomas in adults","volume":"359","author":"Wen","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2026.218668_bib2","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41392-025-02299-4","article-title":"Glioblastoma at the crossroads: current understanding and future therapeutic horizons","volume":"10","author":"Singh","year":"2025","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.canlet.2026.218668_bib3","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1146\/annurev-pathmechdis-042524-025950","article-title":"Immunopathology of glioblastoma","volume":"21","author":"Li","year":"2026","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.canlet.2026.218668_bib4","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/1479-5876-12-107","article-title":"Immunocompetent murine models for the study of glioblastoma immunotherapy","volume":"12","author":"Oh","year":"2014","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.canlet.2026.218668_bib5","first-page":"vdab100","article-title":"Mouse models of glioblastoma for the evaluation of novel therapeutic strategies","volume":"3","author":"Haddad","year":"2021","journal-title":"Neurooncol Adv"},{"key":"10.1016\/j.canlet.2026.218668_bib6","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00262-010-0946-6","article-title":"Experimental immunotherapy for malignant glioma: lessons from two decades of research in the GL261 model","volume":"60","author":"Maes","year":"2011","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.canlet.2026.218668_bib7","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1501137","article-title":"Responsiveness to anti-PD-1 and anti-CTLA-4 immune checkpoint blockade in SB28 and GL261 mouse glioma models","volume":"7","author":"Genoud","year":"2018","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.canlet.2026.218668_bib8","doi-asserted-by":"crossref","first-page":"4178","DOI":"10.1038\/s41467-022-31408-y","article-title":"A brain precursor atlas reveals the acquisition of developmental-like states in adult cerebral tumours","volume":"13","author":"Hamed","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218668_bib9","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/s41586-024-08356-2","article-title":"Gliomagenesis mimics an injury response orchestrated by neural crest-like cells","volume":"638","author":"Hamed","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218668_bib10","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nature03128","article-title":"Identification of human brain tumour initiating cells","volume":"432","author":"Singh","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218668_bib11","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1007\/s10495-025-02123-y","article-title":"Tumor heterogeneity and resistance in glioblastoma: the role of stem cells","volume":"30","author":"Ghosh","year":"2025","journal-title":"Apoptosis"},{"key":"10.1016\/j.canlet.2026.218668_bib12","doi-asserted-by":"crossref","DOI":"10.1172\/JCI205841","article-title":"Uncovering a feedback loop in glioblastoma that reinforces stemness and immunosuppression","volume":"136","author":"Basakis","year":"2026","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.canlet.2026.218668_bib13","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.stem.2009.03.014","article-title":"Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens","volume":"4","author":"Pollard","year":"2009","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.canlet.2026.218668_bib14","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.celrep.2012.12.013","article-title":"Patient-specific orthotopic glioblastoma xenograft models recapitulate the histopathology and biology of human glioblastomas in situ","volume":"3","author":"Joo","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.canlet.2026.218668_bib15","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1101\/pdb.top069831","article-title":"Using the RCAS-TVA system to model human cancer in mice","volume":"2014","author":"Ahronian","year":"2014","journal-title":"Cold Spring Harb. Protoc."},{"key":"10.1016\/j.canlet.2026.218668_bib16","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1593\/tlo.09100","article-title":"Modeling adult gliomas using RCAS\/t-va technology","volume":"2","author":"Hambardzumyan","year":"2009","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.canlet.2026.218668_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci12111426","article-title":"Multiparametric longitudinal profiling of RCAS-tva-Induced PDGFB-driven experimental glioma","volume":"12","author":"Becker","year":"2022","journal-title":"Brain Sci."},{"key":"10.1016\/j.canlet.2026.218668_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12061633","article-title":"Metabolic landscape of a genetically engineered mouse model of IDH1 mutant glioma","volume":"12","author":"Ruiz-Rodado","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.canlet.2026.218668_bib19","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s13000-019-0903-4","article-title":"The role of p-Stat3 Y705 immunohistochemistry in glioblastoma prognosis","volume":"14","author":"Susman","year":"2019","journal-title":"Diagn. Pathol."},{"key":"10.1016\/j.canlet.2026.218668_bib20","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1002\/glia.23594","article-title":"Importance of GFAP isoform-specific analyses in astrocytoma","volume":"67","author":"van Bodegraven","year":"2019","journal-title":"Glia"},{"key":"10.1016\/j.canlet.2026.218668_bib21","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s40478-025-02031-x","article-title":"Endothelial transdifferentiation of glioma stem cells: a literature review","volume":"13","author":"Buruiana","year":"2025","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.canlet.2026.218668_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/cells9122648","article-title":"Cyclin D1 in cancer: a molecular connection for cell cycle control, adhesion and invasion in tumor and stroma","volume":"9","author":"Montalto","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.canlet.2026.218668_bib23","doi-asserted-by":"crossref","DOI":"10.1172\/JCI195556","article-title":"Oligodendrocyte transcription factor 2 orchestrates glioblastoma immune evasion by suppressing CXCL10 and CD8+ T cell activation","volume":"136","author":"Zhang","year":"2026","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.canlet.2026.218668_bib24","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1093\/neuonc\/noaf086","article-title":"Targeting PDGFRA-SHP2 signaling enhances radiotherapy in IDH1-mutant glioma","volume":"27","author":"Yu","year":"2025","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.canlet.2026.218668_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20112746","article-title":"Proneural-mesenchymal transition: phenotypic plasticity to acquire multitherapy resistance in glioblastoma","volume":"20","author":"Fedele","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2026.218668_bib26","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1093\/neuonc\/noae131","article-title":"In vivo mouse models for adult brain tumors: exploring tumorigenesis and advancing immunotherapy development","volume":"26","author":"Figg","year":"2024","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.canlet.2026.218668_bib27","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1101\/gad.324301.119","article-title":"Glioblastoma stem cells: lessons from the tumor hierarchy in a lethal cancer","volume":"33","author":"Gimple","year":"2019","journal-title":"Genes Dev."},{"key":"10.1016\/j.canlet.2026.218668_bib28","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nrn3765","article-title":"A neurocentric perspective on glioma invasion","volume":"15","author":"Cuddapah","year":"2014","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.canlet.2026.218668_bib29","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.ccell.2016.03.027","article-title":"Olig2-Dependent reciprocal shift in PDGF and EGF receptor signaling regulates tumor phenotype and mitotic growth in malignant glioma","volume":"29","author":"Lu","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218668_bib30","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1093\/neuonc\/noaf160","article-title":"Proneural-mesenchymal hybrid glioblastoma cells are resistant to therapy and dependent on nuclear import","volume":"27","author":"Bourmeau","year":"2025","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.canlet.2026.218668_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2025.156111","article-title":"Molecular drivers of epithelial-mesenchymal transition (EMT) in glioblastoma and impact on therapy resistance","volume":"272","author":"Tian","year":"2025","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.canlet.2026.218668_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1098482","article-title":"Roles of STAT3 in the pathogenesis and treatment of glioblastoma","volume":"11","author":"Fu","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.canlet.2026.218668_bib33","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.cell.2019.06.024","article-title":"An integrative model of cellular states, plasticity, and genetics for glioblastoma","volume":"178","author":"Neftel","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2026.218668_bib34","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1093\/neuonc\/noaf177","article-title":"Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions","volume":"27","author":"Wen","year":"2025","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.canlet.2026.218668_bib35","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13045-024-01544-7","article-title":"Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives","volume":"17","author":"Lin","year":"2024","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.canlet.2026.218668_bib36","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/s41571-018-0003-5","article-title":"Current state of immunotherapy for glioblastoma","volume":"15","author":"Lim","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526004313?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526004313?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T23:26:09Z","timestamp":1785885969000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383526004313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":36,"alternative-id":["S0304383526004313"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218668","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The WYZ-1 mouse glioblastoma stem cell model: A novel preclinical tool for tumor and therapy studies","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218668","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"218668"}}